Completed PHASE4 INTERVENTIONAL 2-arm NCT07228481

Study of Two Dosages of Roaccutane in Cystic Acne

Randomised Controlled Trial of Two Different Cumulative Dosages of Roaccutane for Cystic Acne

Sponsor: Premier Specialists, Australia

Updated 2 times since 2025 Last updated: Dec 19, 2025 Started: Jun 26, 2001 Primary completion: Mar 1, 2025 Completion: May 10, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07228481, this PHASE4 trial focuses on Acne Cystic and remains completed. Sponsored by Premier Specialists, Australia, it has been updated 2 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Dec 2025 — Jan 2026 [monthly]

Completed PHASE4

First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Premier Specialists, Australia
Roche Products Limited

Data source: Premier Specialists, Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.